Mepsevii Prices, Coupons, Copay Cards & Patient Assistance
Mepsevii (vestronidase alfa) is a member of the lysosomal enzymes drug class and is commonly used for Mucopolysaccharidosis Type VII.
Mepsevii prices
Intravenous Solution
2 mg/mL Mepsevii intravenous solution from $2,660.89 for 5 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 5 milliliters | $532.18 | $2,660.89 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Mepsevii Coupons, Copay Cards and Rebates
Mepsevii offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Mepsevii UltraCare Copay Assistance Program
Eligible commercially insured patients may receive financial assistance to cover out-of-pockets costs for medication and the cost of administration.
- Applies to:
- Mepsevii
- Number of uses:
- Contact the program
Form more information phone: 888-756-8657 or Visit website
Patient Assistance & Copay Programs for Mepsevii
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: UltraCare Patient Assistance Program
Eligibility requirements:- Determined case by case
- Not Required
- FDA-approved diagnosis
- Must be residing in the US or Puerto Rico
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Mepsevii (vestronidase alfa-vjbk) Injection; IV
More information please phone: 888-756-8657 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Mepsevii (vestronidase alfa)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: lysosomal enzymes
- Breastfeeding
- En español